CD8A and neoplasm: Lymphocytes exhibiting robust anti-tumor potential, including NK-cells, CD8+ T-cells, and gamma-delta (γδ) T-cells with phenotypes associated with migration and cytokine signaling, display elevated surface expression of β2-ARs.